Skip to content

Clinical trials

Lung Neoplasms trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Chile Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20081
20091
20141
20152
20161
20182
20191
20202
20211
20231
20244
20258
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting11
Active, not recruiting6
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC7
Bristol-Myers Squibb5
Amgen2
AstraZeneca2
Gustave Roussy, Cancer Campus, Grand Paris2
Pfizer2
Agennix1
BioNTech SE1
Boehringer Ingelheim1
Genmab1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms32
Carcinoma, Non-Small-Cell Lung18
Carcinoma3
Neoplasms3
Breast Neoplasms2
Lung Diseases2
Adenocarcinoma of Lung1
Anemia1
Cardiotoxicity1
Esophageal Neoplasms1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.